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Abstract
Research on the determinants of condom use and condom non-use generally has relied on self-
reported data with questionable validity. We identified predictors of recent, unprotected sex
among 331 female sex workers in Madagascar using two outcome measures: self-reports of
unprotected sex within the past 48 h and detection of prostate-specific antigen (PSA), a biological
marker of recent semen exposure. Multivariable logistic regression revealed that self-reported
unprotected sex was associated with three factors: younger age, having a sipa (emotional partner)
in the prior seven days, and no current use of hormonal contraception. The sole factor related to
having PSA detected was prevalent chlamydial infection (adjusted odds ratio, 4.5; 95% confidence
interval, 2.0–10.1). Differences in predictors identified suggest that determinants of unprotected
sex, based on self-reported behaviors, might not correlate well with risk of semen exposure.
Caution must be taken when interpreting self-reported sexual behavior measures or when
adjusting for them in analyses evaluating interventions for the prevention of HIV/STIs.
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Introduction
Promoting the use of condoms among high-risk groups, including female sex workers
(FSWs), is considered a cornerstone of controlling the HIV pandemic [1–3]. Accordingly, a
vast body of research has been conducted on the determinants of condom use and non-use
among FSWs. Condom use, among FSWs in Africa, has been associated with age, partner
type, duration of sex work, number of clients, partner violence, prior HIV testing, and access
to condoms [4–9]. Engaging in unprotected sex has been linked to binge drinking, charging
more for the act, pregnancy intentions, knowing other women who have unprotected sex,
older age of the partner, and sex at home [10–14].
Studies generally have identified determinants of condom use and condom non-use with
self-reported data, which have questionable validity [15–19]. The detection of prostate-
specific antigen (PSA) in vaginal fluid is a marker of exposure to semen within the previous
48 h [20–23]. Research suggests that almost all vaginal-swab specimens (97%) will be
negative for PSA (defined as ≤1 ng of PSA/ml eluate) by 48 h after exposure to semen [23].
Thus, the detection of PSA can serve as a measure of recent sex unprotected by a condom or
sex in which a condom either failed or was used incorrectly. We identified predictors of
recent, unprotected sex (measured by both self-reports and PSA detection) and evaluated
whether the associations between factors and the two measures of unprotected sex differed.
Methods
Study Procedures
The study was conducted among FSWs in two sites in Madagascar participating in an 18-
month, randomized controlled trial of the effect of supplementing community-based
promotion of male and female condoms with clinic-based counseling [24, 25]. Participants
attending their last (18-month) study visit between December 2002 and May 2003 were
asked to participate in this additional research, which consisted of answering eight questions
about sex and condom use and having two vaginal swabs collected to test for PSA.
Specifically, we asked participants about any sex acts (yes or no) with any clients, partners,
or boyfriends during four timeframes: the previous 24 h, 48 h, 7 days and 14 days. For each
timeframe, women also were asked to report whether any of the acts were unprotected (yes
or no). As part of the main study visit on that same day, the participants also were
administered a questionnaire, which included questions on potential correlates of
unprotected sex (see below). Both questionnaires were administered by female study
clinicians in a private setting within the clinic.
The same female clinician inserted a cotton-tipped swab into the posterior fornix and rotated
it four times to collect the specimens for testing for PSA. After several hours of air-drying,
staff sealed the swabs in individual transport tubes and froze them until data collection
ended. Specimens were shipped on dry ice to the research laboratory at the University of
North Carolina for processing. Only participants who gave verbal consent for the additional
research were included. The consent process included an explanation that the purpose of the
additional research was to improve ways of measuring when women have unprotected sex.
Ethical review boards at Family Health International and the Madagascar Ministry of Health
approved the additional research. All names and personal identifiers were removed before
researchers at the Centers for Disease Control and Prevention (CDC) received the data, and
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the CDC institutional review board determined that the present analysis of anonymous data
was exempt from review.
Laboratory Methods
We used Abbot IMx microparticle enzyme immunoassay (Abbott Laboratories, Abbott Park,
IL) for detecting PSA in the vaginal swab eluates. After each vaginal swab was inserted into
a 1.5 ml microcentrifuge tube, with 1 ml of phosphate-buffered saline, the contents were
allowed to elute at room temperature for 5–15 min. We vigorously rotated individual
specimens and pressed the swabs against the side of the tube to maximize the recovery of
the sample. Capped tubes then were centrifuged at 13,000×g for 5 min before 250 µl of the
resulting supernatant was dispensed into an IMx reaction cell. We did not perform the
dilution and retesting necessary for quantifying concentrations above 100 ng PSA/ml. To
have a threshold consistent with that of Macaluso and colleagues (who used three times the
volume for eluting vaginal swab specimens), we defined a positive result as >3 ng PSA/ml
vaginal swab eluate [23].
Methods for diagnosing sexually transmitted infections in this study have been reported
elsewhere [24, 25]. Gonorrhea and chlamydial infections were diagnosed with ligase chain
reaction testing (Abbott LCx Probe System, Abbott Laboratories, Abbott Park, IL, USA),
and trichomoniasis was diagnosed by culture using InPouch (Bio-Med, White City, OR,
USA).
Statistical Analysis
We assessed predictors of engaging in recent unprotected sex, using two outcome measures:
self-reports of having had unprotected sex within the previous 48 h and the detection of PSA
in vaginal fluid. Potential correlates included randomization group (peer-only counseling vs.
peer and clinic counseling); study site (Tamatave vs. Antananarivo); age (highest quartile
[≥35 years] vs. younger age); location from which clients were typically recruited (street
only vs. bar, market, other); single without a steady partner (yes vs. no); current hormonal
contraception use (yes vs. no); prevalent chlamydial infection (yes vs. no); prevalent
gonorrhea infection (yes vs. no); prevalent trichomoniasis infection (yes vs. no); number of
sexual partners in previous seven days (0–3 vs. ≥4 [median, 4]); sipas (emotional, non-client
partner) in previous seven days (0 vs. ≥1); number of clients in previous seven days (0, 1–4
vs. ≥5 [median among those with any clients in previous seven days, 5]); when using
condoms with clients, FSW usually suggests their use (yes vs. no); when using condoms
with clients, FSW usually decides between male and female condoms (yes vs. no);
symptoms of STI since last study visit (yes vs. no); told partner to get STI treatment since
last study visit (yes vs. no); reported talking about male and female condoms with clinic
provider (yes vs. no); and reported talking about male and female condoms with peer
educator (yes vs. no).
We simultaneously fit models for the two outcome measures using bivariate logistic
regression [26]. The dataset was augmented to have two records for each FSW (i.e., one for
each outcome measure). Generalized estimating equations (using a logit link function and
unstructured working correlation matrix) were applied to control for the correlation between
outcome measures from the same woman. We chose this approach because assessing
whether two models differ requires a direct comparison of the models; it is generally
insufficient to declare that a difference exists simply because certain factors are significant
in one model but not in the other. We first performed bivariable analyses by fitting
individual models with the outcome type (self-report or PSA test results), the potential
predictor, and the two-way interaction between the outcome type and the potential predictor.
We then constructed a full initial model, which included parameters for outcome type, all
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potential predictors, and the two-way interactions between outcome type and each potential
predictor. We reduced the full model using manual backwards elimination, in which
variables that were not significant at the 0.05 level were removed; variables were only
removed if they were non-significant for both outcomes. We report the P-values for
contrasts, testing the differences in the associations between each potential predictor and the
two outcomes. All analyses were performed by using SAS, version 9.1 (SAS Institute, Cary,
NC).
Results
Of the 347 women who were recruited to participate in this additional research at their last
study visit, all consented to participate. The analysis is restricted to the 331 women who
provided both outcome measures (i.e., self-report and PSA data). The mean age of FSWs
was 29 years (range, 17–52). Most FSWs (81%) solicited their clients on the streets, and few
used oral contraception (6%) or injectable contraception (13%) for pregnancy prevention
(Table 1). At least one breakage or slippage of the male or female condom during sex in the
previous 30 days was reported by 8.5% of FSWs. Condom malfunctions generally were
reported for the use of male condoms rather than female condoms (data not shown). Overall,
29.0% (n = 96) of FSWs reported unprotected sex in the previous 48 h and 38.1% (n = 126)
had PSA detected in their specimens.
In the bivariable analysis, we found two predictors of both self-reported unprotected sex and
having PSA detected in vaginal fluid: (1) having more clients in the previous seven days and
(2) when using condoms with clients, FSW usually decides between male and female
condoms (Table 2). Self-reported unprotected sex also was associated with seven factors that
were not related to having PSA detected: study site, age, having more sexual partners in the
previous seven days, having more than one sipa in the previous seven days, when using
condoms with clients, FSW usually suggests their use, being other than single without a
steady partner, and not having talked about male and female condoms with a provider at the
clinic. The only factor that was associated with PSA, but not associated with self-reported
data, was prevalent chlamydial infection.
In the multivariable analysis, three factors were associated with self-reported unprotected
sex (Table 3). Younger women had a greater odds of self-reported unprotected sex
compared to women 35 years of age or older (adjusted OR [aOR], 2.1; 95% CI 1.1–4.0).
Current hormonal contraception use was protective against unprotected sex (aOR, 0.4; 95%
CI 0.2–0.9). Finally, women who reported having one or more sipas in the previous seven
days, had an odds of reporting unprotected sex 4.8 times (95% CI 2.9–8.1) that of women
without a sipa. The sole predictor of having PSA detected was having a prevalent
chlamydial infection (aOR, 4.5; 95% CI 2.0–10.1). Only the association with having one or
more sipas in the previous seven days was significantly different between the models for the
two outcomes (P-value <0.01).
As a sensitivity analysis, we repeated the analysis after defining a positive PSA result as 15
ng/ml vaginal swab eluate. The use of this higher threshold had a negligible effect on the
effect estimates and did not change any of the conclusions from the multivariable analysis.
Discussion
We found different predictors of unprotected sex in the multivariable analysis, depending on
the outcome measure used. Self-reports of recent, unprotected sex were associated with
younger age, no hormonal contraception use, and having a sipa in the previous seven days.
In contrast, recent, unprotected sex, measured with PSA detection, was associated only with
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having a prevalent chlamydial infection. Prior research conducted among FSWs and non-
FSWs in four West African countries demonstrated an association between PSA detection
and prevalent gonorrhea and chlamydial infections and Mycoplasma genitalium [27].
With a few exceptions, we measured predictors using self-reported data, for which the
validity could not be assessed. Interestingly, the sole predictor of having PSA detected,
chlamydial infection, was based on an objective, laboratory test. The association between
self-reported condom use and a reduction in STI risk has not been consistently demonstrated
[28]. However, the present findings suggest that the fallibility of self-reported data could
have been responsible for the lack of correlation in prior studies.
The main strength of this research involves the use of PSA to measure recent unprotected
sex. To our knowledge, this is the first study to evaluate factors associated with unprotected
sex among FSWs by using both self-reports and a biological measure of semen exposure.
Previous research has highlighted potential problems of relying on self-reported data when
measuring coitus and condom use [29–31]. For example, in a substudy conducted among
135 women participating in a trial evaluating a candidate microbicide, 78% admitted in
follow-up audio computer-assisted self-interviews (ACASI) that they had previously
misreported behaviors at least once during face-to-face interviews for the larger study [19].
Notably, more women described past over-reporting than under-reporting of unprotected
sex. If the data from the ACASI are valid, these findings suggest that we cannot even
assume that bias will always be in the direction of under-reporting of risky behaviors.
Studies have detected apparent under-reporting of unprotected sex by comparing self-reports
to the detection of PSA. A previous report, based on the present study, demonstrated that
29% of the FSWs who reported not engaging in unprotected sex within the previous 48 h,
had PSA detected [16]. Similar studies have found PSA in specimens of 36% of FSWs in
Guinea, 11% of FSWs in Kenya, and 15% of women in Zimbabwe, who denied recent
unprotected sex [17, 18, 32]. Because PSA immediately begins to clear from the vagina
following exposure (with 71% of women testing negative for PSA at 24 h after semen
exposure) [23], these estimates should be interpreted as measuring the lower bound of
under-reporting of unprotected sex. On the other hand, because of the decay period for PSA,
the use of the biomarker likely underestimates the occurrence of unprotected sex in the
previous 48 h. Thus, differences in the predictors of the two methods of measuring
unprotected sex might be explained, at least in part, by this clearance time.
Although the variables that were significantly associated with the two outcomes differed, the
only variable with a significant difference in predictive value was having a sipa in the
previous seven days. With a larger sample size, additional variables might have emerged in
the multivariable analysis as significant predictors for each of the individual outcomes.
Thus, we cannot rule out the possibility that the predictors of the two outcomes might have
shown more agreement—had the study been larger. Another study limitation is that if the
level of condom use was very low, and if most FSWs were engaging in unprotected sex, our
findings might demonstrate predictors of the frequency of sex rather than predictors of
unprotected sex per se. Finally, because the questionnaires did not collect data on condom
breakage or slippage in the previous 48 h, we cannot assess whether PSA detection was the
result of a condom malfunction. However, given the relatively small proportion of women
who reported malfunctions in the prior 30 days, the occurrence of these events within the
previous 48 h might have been rare. Furthermore, the results of the sensitivity analysis
suggest that the differences in the two outcomes are not explained by low levels of semen
exposure.
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The current study was conducted among FSWs in Madagascar who had participated in an
18-month study of condom promotion. Furthermore, the validity of participant responses
could be dependent on a range of factors (e.g., rapport with the interviewers, comprehension
of the questionnaire, order of questions or order of visit procedures). Thus, these results
might not be generalizable to other populations or even to the same population when studied
in other contexts.
The differences in predictors of the two outcomes identified in the present study, suggest
that determinants of unprotected sex or condom use on the basis of self-reported data might
not correlate well with the risk of semen exposure. The variables significantly associated
with self-reported unprotected sex might be more appropriately interpreted as predictors of
the reporting behavior, rather than the behavior of interest (i.e., unprotected sex). Thus, we
cannot rule out that prior studies purporting to identify determinants of condom use or non-
use, instead, might have identified correlates of the reporting of these behaviors. Given the
substantial apparent misreporting in measures of unprotected sex, the use of more objective
outcomes is crucial for understanding behaviors and other factors related to HIV/STI risk. In
the meantime, we must take caution when interpreting self-reported sexual behavior
measures or when adjusting for them in multivariable analyses evaluating interventions for
the prevention of HIV/STIs.
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Table 1
Characteristics of female sex workers in Madagascar (N = 331)
Characteristics N (%)
Randomization group
  Peer-only counseling 165 (49.9)
  Peer counseling and clinic counseling 166 (50.2)
Study site
  Antananarivo 166 (50.2)
  Tamatave 165 (49.9)
Age
  17–34 years 246 (74.3)
  ≥35 years 85 (25.7)
Location where recruit clients
  Street only 268 (81.0)
  Bar, market or other 63 (19.0)
Single without steady partner
  Yes 117 (35.4)
  No 214 (64.7)
Current hormonal contraception use
  Yes 61 (18.4)
  No 270 (81.6)
Prevalent chlamydial infection
  Yes 31 (9.4)
  No 300 (90.6)
Prevalent gonorrhea
  Yes 40 (12.1)
  No 291 (87.9)
Prevalent trichomoniasis
  Yes 35 (10.6)
  No 296 (89.4)
Sexual partners in previous 7 days
  0–3 149 (45.0)
  ≥4 182 (55.0)
Sipasa in previous 7 days
  0 189 (57.6)
  ≥1 139 (42.4)
Clients in previous 7 days
  0 48 (16.3)
  1–4 111 (37.8)
  ≥5 135 (45.9)
When using condoms with clients, FSW usually suggests their use
  Yes 119 (36.2)
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Characteristics N (%)
  No 210 (63.8)
When using condoms with clients, FSW usually decides between male and female condoms
  Yes 83 (25.3)
  No 245 (74.7)
Symptoms of STI since last study visit
  Yes 63 (19.0)
  No 268 (81.0)
Told partner to get STI treatment since last study visit
  Yes 235 (71.0)
  No 96 (29.0)
Reported talking about male and female condoms with clinic provider
  Yes 212 (64.1)
  No 119 (36.0)
Reported talking about male and female condoms with peer educator
  Yes 310 (93.7)
  No 21 (6.3)
STI sexually transmitted infections
a
Sipas are emotional, non-client partners
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